HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kraus, E. Articles by Barclay, A. N. Search for Related Content PubMed PubMed Citation Articles by Kraus, E. Articles by Barclay, A. N.

Cutting Edge: Novel RNA Ligands Able to Bind CD4 Antigen and Inhibit CD4⁺ T Lymphocyte Function¹

Elmar Kraus^*, William James and A. Neil Barclay^2,*

^* Medical Research Council Cellular Immunology Unit, Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom

The value of high affinity-specific reagents in immunology is exemplified by the use of mAbs. Recent in vitro selection methods suggested that oligonucleotides may provide a useful alternative, especially where Abs have been insufficient thus far. We used a systematic evolution of ligands by exponential enrichment (SELEX) procedure to derive high affinity oligonucleotide ligands (aptamers) recognizing CD4. These RNase-resistant aptamers bound with high affinity and specificity as demonstrated using BIAcore (Stevenage, U.K.) technology. They also bound native CD4 on rat lymphocytes and specifically interfered with labeling by high affinity mAbs. All aptamers recognized the same binding site in the CDR2-like region in domain 1 of CD4. The applicability of these aptamers for immunologic studies was clearly demonstrated by their ability to block a fully allogeneic MLR in a CD4-specific manner. The high affinity and stability of aptamers point to their value in the analysis and functional manipulation of the immune system.

This article has been cited by other articles:

				N. M. Sayer, M. Cubin, A. Rhie, M. Bullock, A. Tahiri-Alaoui, and W. James Structural Determinants of Conformationally Selective, Prion-binding Aptamers J. Biol. Chem., March 26, 2004; 279(13): 13102 - 13109. [Abstract] [Full Text] [PDF]

				M. Khati, M. Schuman, J. Ibrahim, Q. Sattentau, S. Gordon, and W. James Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2'F-RNA Aptamers J. Virol., December 1, 2003; 77(23): 12692 - 12698. [Abstract] [Full Text] [PDF]

				A. Tahiri-Alaoui, L. Frigotto, N. Manville, J. Ibrahim, P. Romby, and W. James High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands Nucleic Acids Res., May 15, 2002; 30(10): e45 - e45. [Abstract] [Full Text] [PDF]

				S. D. Jayasena Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics Clin. Chem., September 1, 1999; 45(9): 1628 - 1650. [Abstract] [Full Text] [PDF]